Bsm Clinilab Diagnostic And Imaging Centre Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 21 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.47 Cr
as on 16-11-2024
- Revenue -4.40%
(FY 2023)
- Profit -33.62%
(FY 2023)
- Ebitda -15.13%
(FY 2023)
- Net Worth 12.37%
(FY 2023)
- Total Assets -6.03%
(FY 2023)
About Bsm Clinilab Diagnostic And Imaging Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.47 Cr.
Samiran Banerjee, Mani Banerjee, Mihir Banerjee, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195WB2003PTC096022
- Company No.
096022
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bsm Clinilab Diagnostic And Imaging Centre?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samiran Banerjee  | Director | 07-Apr-2003 | Current |
| Mani Banerjee | Director | 07-Apr-2003 | Current |
| Mihir Banerjee | Director | 07-Apr-2003 | Current |
| Sayantan Banerjee | Director | 07-Sep-2021 | Current |
Financial Performance of Bsm Clinilab Diagnostic And Imaging Centre.
Bsm Clinilab Diagnostic And Imaging Centre Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.4% decrease. The company also saw a substantial fall in profitability, with a 33.62% decrease in profit. The company's net worth Soared by an impressive increase of 12.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bsm Clinilab Diagnostic And Imaging Centre?
In 2023, Bsm Clinilab Diagnostic And Imaging Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 29 Jul 2024 | ₹8.50 M | Open |
Others Creation Date: 11 Mar 2024 | ₹2.78 M | Open |
Hdfc Bank Limited Creation Date: 05 Nov 2013 | ₹3.38 M | Open |
How Many Employees Work at Bsm Clinilab Diagnostic And Imaging Centre?
Unlock and access historical data on people associated with Bsm Clinilab Diagnostic And Imaging Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bsm Clinilab Diagnostic And Imaging Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bsm Clinilab Diagnostic And Imaging Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
